Cell Growth & Differentiation, Vol 9, Issue 4 287-296, Copyright © 1998 by American Association of Cancer Research

ARTICLES

Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin

RJ Shaw, AI McClatchey and T Jacks
Department of Biology and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA.

The neurofibromatosis type II (NF2) tumor suppressor gene is inactivated in the development of familial and sporadic schwannomas and meningiomas. The encoded protein, merlin, is closely related to ezrin, radixin, and moesin, which are members of the band 4.1 family of membrane/cytoskeletal linker proteins. We have examined the localization and effects of overexpressing epitope-tagged full-length isoforms of merlin as well as amino- and carboxyl-terminal truncations. The full-length and the amino-terminal domain of merlin localize to cortical actin, particularly areas of dynamic actin rearrangements such as membrane ruffles. Furthermore, overexpression of the carboxyl half of merlin induces cell death in NIH3T3 cells. The effect is splice-form specific and is not observed in the context of the full-length molecule. Thus, as has been described for the erzin, radixin, and moesin proteins, the activities of the carboxyl-terminal domain of merlin may be suppressed by the amino-terminal domain.

This article has been cited by other articles:

				D. Lallemand, A. L. Saint-Amaux, and M. Giovannini Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells J. Cell Sci., November 15, 2009; 122(22): 4141 - 4149. [Abstract] [Full Text] [PDF]

				B. K. Cole, M. Curto, A. W. Chan, and A. I. McClatchey Localization to the Cortical Cytoskeleton Is Necessary for Nf2/Merlin-Dependent Epidermal Growth Factor Receptor Silencing Mol. Cell. Biol., February 15, 2008; 28(4): 1274 - 1284. [Abstract] [Full Text] [PDF]

				M. Gronholm, L. Vossebein, C. R. Carlson, J. Kuja-Panula, T. Teesalu, K. Alfthan, A. Vaheri, H. Rauvala, F. W. Herberg, K. Tasken, et al. Merlin Links to the cAMP Neuronal Signaling Pathway by Anchoring the RI{beta} Subunit of Protein Kinase A J. Biol. Chem., October 17, 2003; 278(42): 41167 - 41172. [Abstract] [Full Text] [PDF]

				K. Kaempchen, K. Mielke, T. Utermark, S. Langmesser, and C. O. Hanemann Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells Hum. Mol. Genet., June 1, 2003; 12(11): 1211 - 1221. [Abstract] [Full Text] [PDF]

				M. Kressel and B. Schmucker Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15 Hum. Mol. Genet., September 15, 2002; 11(19): 2269 - 2278. [Abstract] [Full Text] [PDF]

				J. L. Kissil, K. C. Johnson, M. S. Eckman, and T. Jacks Merlin Phosphorylation by p21-activated Kinase 2 and Effects of Phosphorylation on Merlin Localization J. Biol. Chem., March 15, 2002; 277(12): 10394 - 10399. [Abstract] [Full Text] [PDF]

				A.-M. Bashour, J.-J. Meng, W. Ip, M. MacCollin, and N. Ratner The Neurofibromatosis Type 2 Gene Product, merlin, Reverses the F-Actin Cytoskeletal Defects in Primary Human Schwannoma Cells Mol. Cell. Biol., February 15, 2002; 22(4): 1150 - 1157. [Abstract] [Full Text] [PDF]

				K. M. M. Schulze, C. O. Hanemann, H. W. Muller, and H. Hanenberg Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis Hum. Mol. Genet., January 1, 2002; 11(1): 69 - 76. [Abstract] [Full Text] [PDF]

				E Brault, A Gautreau, M Lamarine, I Callebaut, G Thomas, and L Goutebroze Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain J. Cell Sci., January 5, 2001; 114(10): 1901 - 1912. [Abstract] [PDF]

				L. Goutebroze, E. Brault, C. Muchardt, J. Camonis, and G. Thomas Cloning and Characterization of SCHIP-1, a Novel Protein Interacting Specifically with Spliced Isoforms and Naturally Occurring Mutant NF2 Proteins Mol. Cell. Biol., March 1, 2000; 20(5): 1699 - 1712. [Abstract] [Full Text]

				M. Giovannini, E. Robanus-Maandag, M. Niwa-Kawakita, M. van der Valk, J. M. Woodruff, L. Goutebroze, P. Mérel, A. Berns, and G. Thomas Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein Genes & Dev., April 15, 1999; 13(8): 978 - 986. [Abstract] [Full Text]